Summer 2026 - Undergraduate Translational Development Internship at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Current student majoring in a field related to biomedical sciences (cancer biology, cellular immunology, molecular oncology, genomics)
Interpersonal and collaboration skills, including the willingness and ability to foster working relationships with a range of stakeholders and work independently
Flexible to changing priorities
Prior experience in analyzing genomic and epigenomic data (WGS/WES, Methylome, Transcriptome and familiar with ctDNA) is preferred
Available full time (40hrs/week) throughout the internship period (early June through mid-August 2026)
Authorized to work in the US both at the time of hire and for the duration of employment (no immigration or visa sponsorship available)

Responsibilities

Actively contribute to experimental design and execution of a translational project aligned with GI/GU Disease Team, Translational Development
Participate in BMS student internship requirements
Conduct literature/data review to understand project context, impact and timely communication of data
Present internship project to the Translational Development group at the conclusion of the internship

Skills

Key technologies and capabilities for this role

BioinformaticsEpigeneticsMethylation AnalysisColorectal CancerctDNABiomarkersTranslational ResearchTumor Biology

Questions & Answers

Common questions about this position

What is the duration and timing of the internship?

The full-time internship is 10 weeks long and will take place from June to August 2026.

What benefits does Bristol Myers Squibb offer to interns?

This information is not specified in the job description.

What qualifications and experience are required for this internship?

Candidates must be current students majoring in biomedical sciences fields like cancer biology, cellular immunology, molecular oncology, or genomics, with prior experience in analyzing genomic data, strong interpersonal and collaboration skills, and the ability to work independently.

What is the company culture like at Bristol Myers Squibb?

The culture is challenging, meaningful, and life-changing, with uniquely interesting work, opportunities to grow alongside high-achieving teams, and a focus on balance and flexibility.

What makes a strong candidate for this internship?

A strong candidate is a talented, highly motivated self-starter with enthusiasm for working with complex data sets, critical thinking skills, and interest in learning about translational development and CRC biology.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free